Caroline Lascoux-Combe Selected Research

Caroline Lascoux-Combe Research Topics

11	Infections 01/2022 - 02/2006
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 02/2006
10	Hepatitis B 12/2021 - 05/2012
7	Coinfection 10/2021 - 04/2011
6	Fibrosis (Cirrhosis) 01/2019 - 02/2006
5	HIV Infections (HIV Infection) 01/2022 - 02/2006
4	Chronic Hepatitis B 07/2020 - 05/2012
1	Hepatitis E 10/2021
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 03/2017
1	Autoimmune Diseases (Autoimmune Disease) 03/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Coronary Disease (Coronary Heart Disease) 03/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2015
1	Anemia 12/2014
1	Viremia 09/2013
1	Hepatitis C 04/2011
1	Pulmonary Arterial Hypertension 01/2008
1	Portal Hypertension 01/2007
1	Ascites 01/2007
1	Cholestasis 01/2007

8	Tenofovir (Viread)FDA Link 12/2021 - 01/2010
7	Hepatitis B e AntigensIBA 10/2021 - 04/2011
7	AntigensIBA 10/2021 - 05/2012
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2021 - 02/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
4	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2014
3	Protease Inhibitors (Protease Inhibitor)IBA 07/2020 - 01/2007
3	Antiviral Agents (Antivirals)IBA 10/2016 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 06/2009
1	dolutegravirIBA 01/2022
1	Circular DNAIBA 11/2020
1	AntibodiesIBA 10/2017
1	AutoantibodiesIBA 03/2017
1	Immunoglobulin G (IgG)IBA 03/2017
1	Ribavirin (Virazole)FDA LinkGeneric 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	CholesterolIBA 03/2015
1	Erythropoietin FDA Link 12/2014
1	VaccinesIBA 09/2013
1	efavirenz (Sustiva)FDA Link 02/2006
1	Surface Antigens (Surface Antigen)IBA 02/2006

8	Therapeutics 07/2020 - 01/2008
1	Art Therapy 10/2021
1	Duration of Therapy 01/2019
1	Highly Active Antiretroviral Therapy (HAART) 03/2017
1	Drug Tapering 12/2014
1	Blood Transfusion (Blood Transfusions) 12/2014
1	Liver Transplantation 01/2007